These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
486 related items for PubMed ID: 22317764
1. Frequency of driver mutations in lung adenocarcinoma from female never-smokers varies with histologic subtypes and age at diagnosis. Zhang Y, Sun Y, Pan Y, Li C, Shen L, Li Y, Luo X, Ye T, Wang R, Hu H, Li H, Wang L, Pao W, Chen H. Clin Cancer Res; 2012 Apr 01; 18(7):1947-53. PubMed ID: 22317764 [Abstract] [Full Text] [Related]
2. Frequency of well-identified oncogenic driver mutations in lung adenocarcinoma of smokers varies with histological subtypes and graduated smoking dose. Li H, Pan Y, Li Y, Li C, Wang R, Hu H, Zhang Y, Ye T, Wang L, Shen L, Sun Y, Chen H. Lung Cancer; 2013 Jan 01; 79(1):8-13. PubMed ID: 23098378 [Abstract] [Full Text] [Related]
3. [Correlation between common driver gene variations and clinicopathological typing in lung adenocarcinoma]. Ma XL, Jia RN, Han K, Zhang YX. Zhonghua Bing Li Xue Za Zhi; 2024 Jun 08; 53(6):578-584. PubMed ID: 38825903 [Abstract] [Full Text] [Related]
4. Spectrum of oncogenic driver mutations in lung adenocarcinomas from East Asian never smokers. Li C, Fang R, Sun Y, Han X, Li F, Gao B, Iafrate AJ, Liu XY, Pao W, Chen H, Ji H. PLoS One; 2011 Jun 08; 6(11):e28204. PubMed ID: 22140546 [Abstract] [Full Text] [Related]
5. ALK, ROS1 and RET fusions in 1139 lung adenocarcinomas: a comprehensive study of common and fusion pattern-specific clinicopathologic, histologic and cytologic features. Pan Y, Zhang Y, Li Y, Hu H, Wang L, Li H, Wang R, Ye T, Luo X, Zhang Y, Li B, Cai D, Shen L, Sun Y, Chen H. Lung Cancer; 2014 May 08; 84(2):121-6. PubMed ID: 24629636 [Abstract] [Full Text] [Related]
6. [Correlation of clinicopathologic features and driver gene mutation in non-small cell lung cancer]. Chen LF, Chen XY, Yu XB. Zhonghua Bing Li Xue Za Zhi; 2016 Apr 08; 45(4):221-5. PubMed ID: 27033383 [Abstract] [Full Text] [Related]
7. Unique prevalence of oncogenic genetic alterations in young patients with lung adenocarcinoma. Tanaka K, Hida T, Oya Y, Yoshida T, Shimizu J, Mizuno T, Kuroda H, Sakakura N, Yoshimura K, Horio Y, Sakao Y, Yatabe Y. Cancer; 2017 May 15; 123(10):1731-1740. PubMed ID: 28177518 [Abstract] [Full Text] [Related]
11. The clinicopathological significance of ALK rearrangements and KRAS and EGFR mutations in primary pulmonary mucinous adenocarcinoma. Qu Y, Che N, Zhao D, Zhang C, Su D, Zhou L, Zhang L, Wang C, Zhang H, Wei L. Tumour Biol; 2015 Aug 15; 36(8):6417-24. PubMed ID: 25813151 [Abstract] [Full Text] [Related]
17. Smoking status and self-reported race affect the frequency of clinically relevant oncogenic alterations in non-small-cell lung cancers at a United States-based academic medical practice. Yamaguchi N, Vanderlaan PA, Folch E, Boucher DH, Canepa HM, Kent MS, Gangadharan SP, Majid A, Kocher ON, Goldstein MA, Huberman MS, Costa DB. Lung Cancer; 2013 Oct 15; 82(1):31-7. PubMed ID: 23932486 [Abstract] [Full Text] [Related]
18. [Relevance of molecular alterations in histopathologic subtyping of lung adenocarcinoma based on 2011 International Multidisciplinary Lung Adenocarcinoma Classification]. Liu B, Shi SS, Wang X, Xu Y, Zhang XH, Yu B, Lu ZF, Wang JD, Zhou XJ. Zhonghua Bing Li Xue Za Zhi; 2012 Aug 15; 41(8):505-10. PubMed ID: 23157740 [Abstract] [Full Text] [Related]